Bigtincan(R) Announces Spring Release 2020 to Empower Remote Workers With New Capabilities for Document Automation, Internal Communication, and Sales Readiness 2.0.
Jun 11, 2020 08:00 HKT |  |
|
Sapphire to Strategically Divest 43.87% Equity Stake of Subsidiary Ranken Railway for Cash Consideration of RMB 280 Million
Jun 02, 2020 18:00 HKT |  |
|
Greenbriar to Seek Uplift to the Nasdaq Global Market
Jun 01, 2020 12:00 HKT |  |
|
New Study Underscores How Heated Tobacco Products Are Disrupting the Cigarette Industry
May 31, 2020 11:00 HKT |  |
|
Bigtincan(R) Recognized by SIIA as Best Sales Enablement Platform
May 21, 2020 21:00 HKT | |
|
OmniSci Records Best Quarter in Company History
May 20, 2020 16:00 HKT |  |
|
Greenbriar Capital Corp Reaches Commercial Agreement with the Puerto Rico Electric Power Authority
May 20, 2020 06:00 HKT | |
|
禹洲地产(01628.HK)获纳入恒生大中型股价值50指数及恒生大中型股价值偏向指数
May 19, 2020 17:40 HKT | |
|
禹洲地產(01628.HK)獲納入恒生大中型股價值50指數及恒生大中型股價值偏向指數
May 19, 2020 17:39 HKT | |
|
Southern Asset Management's Li Haipeng Sees Promising Future for Bond Index Funds
May 15, 2020 16:00 HKT |  |
|
Blood on the streets: is it the right time to invest?
May 14, 2020 01:00 HKT |  |
|
Greenbriar Capital Corp Provides Montalva Project Update
May 08, 2020 13:00 HKT | |
|
Greenbriar Capital Corp Reports $3,230,974 or $0.16 per Share of Net Income for Fiscal 2019
Apr 30, 2020 23:00 HKT | |
|
Mr. Shi Bo, Southern Asset Management: Creating Long-term Value with Diligence and Professionalism
Apr 24, 2020 09:00 HKT | |
|
Azabu Insights: Mask Usage in Tokyo Reaches Ninety-Seven Percent And Other Reasons Asian Countries Are Winning Against Coronavirus
Apr 23, 2020 23:00 HKT |  |
|
以色列生物技术公司SuperTrans Medical宣布从韩国Mediforum公司获得200万美元的战略投资
Apr 07, 2020 21:00 HKT |  |
|
以色列生物技術公司SuperTrans Medical宣布從韓國Mediforum公司獲得200萬美元的戰略投資
Apr 07, 2020 21:00 HKT | |
|
Greenbriar Executes Cooperation Agreement with China Machinery Engineering Corporation to Build the Large Montalva Solar Facility
Apr 07, 2020 13:00 HKT | |
|
AIM ImmunoTech(AIM)和深圳Smoore科技公司宣布，双方就研究一种采用创新型Smoore吸入给药装置和Ampligen(葡萄糖酸内酯)作为大流行的SARS-CoV-2潜在的、易于使用的治疗方法达成协议
Apr 07, 2020 11:00 HKT |  |
|
AIM ImmunoTech(AIM)和深圳Smoore科技公司宣布，雙方就研究一種採用創新型Smoore吸入給藥裝置和Ampligen(葡萄糖酸內酯)作為大流行的SARS-CoV-2潛在的、易於使用的治療方法達成協議
Apr 07, 2020 11:00 HKT | |
|